DJ Abbott Laboratories Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories $(ABT)$ slipped 1.61% to $105.46 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.51% to 6,506.48 and Dow Jones Industrial Average falling 0.96% to 45,577.47.
This was the stock's third consecutive day of losses.
Abbott Laboratories closed 24.16% short of its 52-week high of $139.06, which the company reached on June 24th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 0.94% to $235.37, Pfizer Inc. $(PFE)$ fell 1.61% to $26.97, and Merck & Co. Inc. $(MRK)$ fell 0.02% to $114.18.
Trading volume (80.4 M) eclipsed its 50-day average volume of 10.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 20, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 20, 2026 16:35 ET (20:35 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments